Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice

Using the T-REx (Invitrogen, California) gene switch technology and a dominant-negative mutant polypeptide of herpes simplex virus 1 (HSV-1)-origin binding protein UL9, we previously constructed a glycoprotein D-expressing replication-defective and dominant-negative HSV-1 recombinant viral vaccine,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Akhrameyeva, Natalie V., Zhang, Pengwei, Sugiyama, Nao, Behar, Samuel M., Yao, Feng
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2011
Teme:
Vaccines and Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126160/
https://ncbi.nlm.nih.gov/pubmed/21389121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02548-10
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki